Managed Asset Portfolios’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.9M | Buy |
165,519
+1,231
| +0.7% | +$185K | 2.96% | 11 |
|
|
2026
Q1 | $25.1M | Sell |
164,288
-34,348
| -17% | -$5.27M | 3.01% | 14 |
|
|
2025
Q4 | $27.4M | Sell |
198,636
-66
| -0% | -$8.64K | 3.31% | 11 |
|
|
2025
Q3 | $25.5M | Buy |
198,702
+1,662
| +0.8% | +$203K | 3.15% | 14 |
|
|
2025
Q2 | $23.8M | Buy |
197,040
+2,290
| +1% | +$258K | 3.1% | 13 |
|
|
2025
Q1 | $21.7M | Buy |
194,750
+1,733
| +0.9% | +$184K | 3.01% | 14 |
|
|
2024
Q4 | $18.8M | Sell |
193,017
-342
| -0.2% | -$36.5K | 2.78% | 15 |
|
|
2024
Q3 | $22.2M | Sell |
193,359
-51,451
| -21% | -$5.84M | 3.14% | 15 |
|
|
2024
Q2 | $26.1M | Sell |
244,810
-14,212
| -5% | -$1.43M | 3.86% | 8 |
|
|
2024
Q1 | $25.1M | Sell |
259,022
-16,789
| -6% | -$1.72M | 3.65% | 9 |
|
|
2023
Q4 | $27.8M | Buy |
275,811
+1,607
| +0.6% | +$155K | 4.22% | 6 |
|
|
2023
Q3 | $27.9M | Sell |
274,204
-53,162
| -16% | -$5.4M | 4.28% | 6 |
|
|
2023
Q2 | $33M | Sell |
327,366
-44,872
| -12% | -$4.49M | 4.96% | 5 |
|
|
2023
Q1 | $34.2M | Sell |
372,238
-44,992
| -11% | -$3.93M | 5.2% | 3 |
|
|
2022
Q4 | $37.9M | Sell |
417,230
-4,597
| -1% | -$387K | 5.92% | 2 |
|
|
2022
Q3 | $32.1M | Sell |
421,827
-435
| -0.1% | -$36.1K | 5.69% | 2 |
|
|
2022
Q2 | $35.7M | Buy |
422,262
+5,079
| +1% | +$446K | 5.67% | 2 |
|
|
2022
Q1 | $36.6M | Buy |
417,183
+30,260
| +8% | +$2.62M | 5.02% | 7 |
|
|
2021
Q4 | $33.8M | Buy |
386,923
+5,145
| +1% | +$427K | 4.78% | 8 |
|
|
2021
Q3 | $31.2M | Buy |
381,778
+1,117
| +0.3% | +$100K | 4.75% | 8 |
|
|
2021
Q2 | $34.7M | Buy |
380,661
+32,701
| +9% | +$2.91M | 5.17% | 6 |
|
|
2021
Q1 | $29.7M | Buy |
347,960
+11,198
| +3% | +$1M | 4.78% | 8 |
|
|
2020
Q4 | $31.8M | Buy |
336,762
+826
| +0.2% | +$72.2K | 5.59% | 5 |
|
|
2020
Q3 | $29.2M | Buy |
335,936
+5,002
| +2% | +$433K | 5.81% | 4 |
|
|
2020
Q2 | $28.9M | Sell |
330,934
-2,028
| -0.6% | -$175K | 6.27% | 5 |
|
|
2020
Q1 | $27.5M | Buy |
332,962
+19,511
| +6% | +$1.74M | 7.32% | 1 |
|
|
2019
Q4 | $29.7M | Buy |
313,451
+18,610
| +6% | +$1.67M | 6.21% | 5 |
|
|
2019
Q3 | $25.6M | Buy |
294,841
+11,387
| +4% | +$1.02M | 5.62% | 7 |
|
|
2019
Q2 | $25.9M | Sell |
283,454
-21,909
| -7% | -$1.85M | 5.86% | 6 |
|
|
2019
Q1 | $26.3M | Buy |
305,363
+11,173
| +4% | +$897K | 6.51% | 4 |
|
|
2018
Q4 | $22.6M | Buy |
294,190
+9,494
| +3% | +$739K | 6.49% | 3 |
|
|
2018
Q3 | $22M | Buy |
284,696
+11,852
| +4% | +$876K | 5.82% | 5 |
|
|
2018
Q2 | $18.5M | Buy |
272,844
+8,300
| +3% | +$573K | 5.42% | 7 |
|
|
2018
Q1 | $19.2M | Buy |
264,544
+5,886
| +2% | +$448K | 6.16% | 6 |
|
|
2017
Q4 | $19.5M | Buy |
258,658
+4,851
| +2% | +$366K | 6.16% | 5 |
|
|
2017
Q3 | $19.5M | Buy |
253,807
+17,617
| +7% | +$1.33M | 6.08% | 3 |
|
|
2017
Q2 | $17.7M | Buy |
236,190
+7,427
| +3% | +$526K | 5.83% | 4 |
|
|
2017
Q1 | $15.2M | Buy |
228,763
+21,334
| +10% | +$1.42M | 5.46% | 6 |
|
|
2016
Q4 | $13.5M | Buy |
207,429
+4,354
| +2% | +$282K | 5.33% | 6 |
|
|
2016
Q3 | $14.4M | Buy |
203,075
+1,673
| +0.8% | +$122K | 6.05% | 3 |
|
|
2016
Q2 | $14.9M | Buy |
201,402
+11,538
| +6% | +$797K | 6.52% | 3 |
|
|
2016
Q1 | $12.3M | Buy |
189,864
+22,566
| +13% | +$1.54M | 5.55% | 4 |
|
|
2015
Q4 | $12.9M | Buy |
167,298
+24,767
| +17% | +$1.97M | 6.13% | 4 |
|
|
2015
Q3 | $11.7M | Buy |
142,531
+8,470
| +6% | +$754K | 6.03% | 3 |
|
|
2015
Q2 | $11.8M | Buy |
134,061
+804
| +0.6% | +$73.8K | 6.19% | 2 |
|
|
2015
Q1 | $11.8M | Buy |
133,257
+11,707
| +10% | +$1.04M | 6.32% | 2 |
|
|
2014
Q4 | $10.1M | Buy |
121,550
+736
| +0.6% | +$61K | 5.64% | 4 |
|
|
2014
Q3 | $10.2M | Buy |
120,814
+6,607
| +6% | +$535K | 5.94% | 4 |
|
|
2014
Q2 | $9.26M | Sell |
114,207
-108
| -0.1% | -$8.49K | 5.66% | 4 |
|
|
2014
Q1 | $8.71M | Sell |
114,315
-2,073
| -2% | -$151K | 5.92% | 3 |
|
|
2013
Q4 | $8.38M | Buy |
+116,388
| New | +$8.09M | 5.88% | 4 |
|
Other funds holding NVS
TAM
SI
CPC
Managed Asset Portfolios's NVS Position: Q2 2026 in Review
Managed Asset Portfolios increased its Novartis (NVS) stake by 0.75% in Q2 2026, buying an estimated $185K and bringing the position to 165,519 shares worth $25.9M. The position accounts for 2.96% of the portfolio, ranked #11.
Managed Asset Portfolios first reported a position in NVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $37.9M in Q4 2022. 951 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Managed Asset Portfolios held 165,519 shares of Novartis worth $25.9M as of Q2 2026.
- Managed Asset Portfolios bought 1,231 Novartis shares in Q2 2026, an estimated $185K.
- Novartis made up 2.96% of Managed Asset Portfolios's portfolio in Q2 2026, its #11 holding.
- Managed Asset Portfolios first reported a position in Novartis in Q4 2013 and has held it in 51 quarters since.
- Managed Asset Portfolios's Novartis position peaked at $37.9M in Q4 2022.
- 951 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Managed Asset Portfolios's 13F filing for Q2 2026, filed 6 Aug 2026.